Our results showing that RANTES/CCL5 is capable of inducing MMP-1 and MMP-13 expression and collagenase activity and may also contribute to IL-1β-induced destruction further implicates RANTES/CCL5 as a potent mediator of bone and cartilage damage in RA. Here, CCL5 is linked to rheumatoid arthritis.